6
Publications
157
Citations
6
H-Index
2016
Active since
Fengwei Zhu is an author at Nantong University specializing in cancer therapeutics, lung cancer, and radiation oncology.
Publications per year
2016–2024
6
6
GLI1 activation is a key mechanism of erlotinib resistance in human non‑small cell lung cancer
Zhouhuan Dong, Yun Wang, Vivianne W. Ding et al. · Oncology Letters · 2020 · 17 citations · Full text
Rows per page
1–5 of 6